240 related articles for article (PubMed ID: 27785426)
1. Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?
Klaile Y; Schlack K; Boegemann M; Steinestel J; Schrader AJ; Krabbe LM
Transl Androl Urol; 2016 Oct; 5(5):692-701. PubMed ID: 27785426
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.
Pokuri VK; Syed JR; Yang Z; Field EP; Cyriac S; Pili R; Levine EG; Azabdaftari G; Trump DL; Guru K; George S
Clin Genitourin Cancer; 2016 Feb; 14(1):e59-65. PubMed ID: 26508364
[TBL] [Abstract][Full Text] [Related]
3. Histologically confirmed distant metastatic urothelial carcinoma from the urinary bladder: a retrospective review of one institution's 20-year experience.
Yoo Y; Lee J; Park HS; Cho MS; Sung SH; Park S; Choi E
J Pathol Transl Med; 2021 Mar; 55(2):94-101. PubMed ID: 33260285
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of bladder urothelial carcinoma with squamous differentiation.
Raman JD; Jafri SM
Urol Oncol; 2015 Oct; 33(10):429-33. PubMed ID: 26206104
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
[TBL] [Abstract][Full Text] [Related]
6. Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls.
Arita Y; Woo S; Kwee TC; Shigeta K; Ueda R; Nalavenkata S; Edo H; Miyai K; Das J; Andrieu PIC; Vargas HA
Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38847848
[TBL] [Abstract][Full Text] [Related]
7. Intracytoplasmic Lumen in Urine Cytology Predicts Worse Prognosis in Non-Muscle-Invasive Bladder Cancers.
Terauchi T; Nakada S; Takenaka M; Mizuguchi S; Okanemasa Y; Tsubata Y; Miyazawa K; Kinjo M; Shioya A; Guo X; Kurose N; Yamada S
Acta Cytol; 2020; 64(4):360-367. PubMed ID: 32097951
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
[TBL] [Abstract][Full Text] [Related]
9. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB
Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Patients With T1 Nested Variant of Urothelial Carcinoma Compared to Pure Urothelial Carcinoma of the Bladder.
Mally AD; Tin AL; Lee JK; Satasivam P; Cha EK; Donat SM; Herr HW; Bochner BH; Sjoberg DD; Dalbagni G
Clin Genitourin Cancer; 2017 Jul; ():. PubMed ID: 28802887
[TBL] [Abstract][Full Text] [Related]
11. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
[TBL] [Abstract][Full Text] [Related]
12. The optimal management of variant histology in muscle invasive bladder cancer.
Tiwari RV; Ngo NT; Lee LS
Transl Androl Urol; 2020 Dec; 9(6):2965-2975. PubMed ID: 33457269
[TBL] [Abstract][Full Text] [Related]
13. The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?
Monn MF; Kaimakliotis HZ; Cary KC; Bihrle R; Pedrosa JA; Masterson TA; Foster RS; Gardner TA; Cheng L; Koch MO
BJU Int; 2015 Aug; 116(2):236-40. PubMed ID: 25060358
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
[TBL] [Abstract][Full Text] [Related]
15. The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer.
Gofrit ON; Yutkin V; Shapiro A; Pizov G; Zorn KC; Hidas G; Gielchinsky I; Duvdevani M; Landau EH; Pode D
Front Oncol; 2016; 6():43. PubMed ID: 27014622
[TBL] [Abstract][Full Text] [Related]
16. What About Variant Histologies in Bladder Cancer?
Day E; Gavira J; Tapia JC; Anguera G; Maroto P
Eur Urol Focus; 2024 Jun; ():. PubMed ID: 38849276
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
[TBL] [Abstract][Full Text] [Related]
18. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?
Linder BJ; Boorjian SA; Cheville JC; Sukov WR; Thapa P; Tarrell RF; Frank I
J Urol; 2013 Nov; 190(5):1692-6. PubMed ID: 23707452
[TBL] [Abstract][Full Text] [Related]
19. Urothelial Carcinoma In Situ of the Bladder With Glandular Differentiation: Report of 92 Cases.
Yang Z; Epstein JI
Am J Surg Pathol; 2018 Jul; 42(7):971-976. PubMed ID: 29683821
[TBL] [Abstract][Full Text] [Related]
20. Malignant non-urothelial neoplasms of the urinary bladder: a review.
Dahm P; Gschwend JE
Eur Urol; 2003 Dec; 44(6):672-81. PubMed ID: 14644119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
